Health-related quality of life associated with different cervical cancer therapies received by patients in two Nigerian tertiary hospitals
- PMID: 38357130
- PMCID: PMC10862647
- DOI: 10.4314/ahs.v23i3.32
Health-related quality of life associated with different cervical cancer therapies received by patients in two Nigerian tertiary hospitals
Abstract
Background: There are important consequences from cervical cancer (CC) disease and its treatment among survivors, especially the impact on quality of life (QoL).
Objective: To evaluate the health-related QoL associated with different CC therapies received by patients in two Nigerian tertiary hospitals.
Methods: This study employed a prospective longitudinal design. It was conducted at Usmanu Danfodiyo University Teaching Hospital, Sokoto and Ahmadu Bello University Teaching Hospital Zaria, North-Western Nigeria. Data of all the 157 eligible CC patients were collected at baseline and after therapy. Data analysis was done with appropriate descriptive and inferential statistics using SPSS V. 20 for windows. P<0.05 was considered statistically significant.
Results: Chemotherapy (CT) was the major therapy option received by 78(49.7%) of the patients. Patients who received chemoradiation therapy (CRT) and adjuvant chemotherapy (CTS) had the highest increase in mean overall health-related QoL of 0.138 (t=8.456, p<0.001) and 0.138 (t=6.489, p<0.001) higher than their respective baseline scores. Patients who received CT had the least increase in mean overall health-related QoL of 0.095 (t=4.574, p<0.001) from baseline.
Conclusion: Chemoradiation therapy and adjuvant chemotherapy were associated with highest increase in mean overall health-related QoL. Chemotherapy was associated with the least increase in mean overall health-related QoL.
Keywords: Cervical cancer; quality of life; therapies.
© 2023 Samaila A et al.
Conflict of interest statement
No conflict of interest to disclose.
Similar articles
-
Health-related quality of life among cervical cancer survivors at a tertiary hospital in Ghana.PLoS One. 2022 Jun 3;17(6):e0268831. doi: 10.1371/journal.pone.0268831. eCollection 2022. PLoS One. 2022. PMID: 35657957 Free PMC article.
-
Human immunodeficiency virus seroprevalence in patients with invasive cervical cancer in Zaria, North-Western Nigeria.Ann Afr Med. 2018 Jan-Mar;17(1):17-21. doi: 10.4103/aam.aam_37_17. Ann Afr Med. 2018. PMID: 29363631 Free PMC article.
-
A study of modifiable factors associated with health-related quality of life in long-term cervical cancer survivors.Acta Obstet Gynecol Scand. 2023 Feb;102(2):218-225. doi: 10.1111/aogs.14490. Epub 2023 Jan 23. Acta Obstet Gynecol Scand. 2023. PMID: 36683549 Free PMC article.
-
Comparison of neoadjuvant treatments followed by radical surgery or chemoradiation on quality of life in patients with stage IB2-IIA cervical cancer.Gynecol Oncol. 2020 May;157(2):536-541. doi: 10.1016/j.ygyno.2020.01.039. Epub 2020 Mar 13. Gynecol Oncol. 2020. PMID: 32173046
-
A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer.Gynecol Oncol. 2006 Sep;102(3):563-72. doi: 10.1016/j.ygyno.2006.03.050. Epub 2006 May 22. Gynecol Oncol. 2006. PMID: 16716379 Review.
Cited by
-
Editor's choice: Sexual reproductive health, child issues, NCDs, surgery, infections and health systems - a salad of sorts.Afr Health Sci. 2023 Sep;23(3):i-vi. doi: 10.4314/ahs.v23i3.1. Afr Health Sci. 2023. PMID: 38357140 Free PMC article. No abstract available.
References
-
- Daniel N, Nwobodo Emmanuel I, R AL, Magaji A M, Siddique S. Screening for Cervical Cancer: Experience from a University Hospital in North Western Nigeria (2007 2009) J Basic Clin Reprod Sci. 2013;2(1):18–22.
-
- Sule AA, Ochicha O. A histopathologic review of cervical cancer in Kano, Nigeria. Sahel Med J. 2017;20(1):16–20.
-
- Onyenwenyi AOC, Gugu GM. Strategies for the Prevention and Control of Cervical Cancer in Rural Communities: A Nigerian Perspective. J Community Med Prim Heal Care. 2016;28(2):77–93.
-
- Hyuna S, Jacques F, Rebecca LS, Mathieu L, Isabelle S, Ahmedin J, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca Cancer J Clin. 2021;021(71):209–249. - PubMed
-
- NCCN, author. Clinical Practice Guidelines in Oncology: Cervical Cancer. Version 4.2019 [Internet] 2019. Apr 2, 2019, Available from: https://www2.tri-kobe.org/nccn/guideline/gynecological/english/cervical.pdf.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials